ReviewMicrobial ecology2024
Paenibacillus as a Biocontrol Agent for Fungal Phytopathogens: Is P. polymyxa the Only One Worth Attention?
Review in Microbial ecology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Article
- Biocontrol of Fungal Pathogens of Winter Oilseed Rape (Molecules (Basel, Switzerland) · 2026Article
- Optimized Fermentation of EndophyticMicroorganisms · 2026Article
- Protective Rhizobacterial Strains Against Black Shoot Blight Caused by Erwinia pyrifoliae on Apple Plants.The plant pathology journal · 2026Article
- Molecular Identification and Recombinant Expression of a Novel Antifungal Protein from Wheat-AssociatedToxins · 2026Article
- Complete genome sequences of soil-associatedMicrobiology resource announcements · 2026Article
- Integrated genomic and phenotypic analysis of an endophytic bacterium reveals biocontrol and plant growth-promoting mechanisms.iScience · 2026Article
- Fusaricidins producing Paenibacillus: a potential biocontrol agent against plant pathogens.Archives of microbiology · 2026Review
- Screening and identification of a new antimicrobial,RSC advances · 2026Article
- Paenidepsins are a Family of Lipopeptides fromJournal of natural products · 2026Article
- Isolation and characterization of a novel strain, Paenibacillus lacisediminis sp. nov., exhibiting both biomacromolecule degradation and plant growth-beneficial activities.BMC microbiology · 2026Article
- Comparative genomic analyses reveal key traits for biocontrol and the promotion of plant growth in Paenibacillus strains.World journal of microbiology & biotechnology · 2026Article
- Article
- Linking microbiome structure to functional analysis identifies resilientFrontiers in microbiology · 2026Article
- Microbial inoculation enhanced the thermophilic phase and improved final maturity-related properties of coffee husk composting for tomato seedling substrate production.Frontiers in plant science · 2026Article
- Unravelling the Mechanistic Role of Soil Microbial Interactions in the Suppression of Phytopathogens in Vegetable Agroecosystems of Pakistan.Current microbiology · 2025Review
- Pseudomonas protegens as a biocontrol agent against phytopathogenic fungi - mini review.World journal of microbiology & biotechnology · 2025Review
- Bioprotective Strategies to ControlInternational journal of molecular sciences · 2025Review
- Role of plant growth-promoting bacteria (PGPB) in enhancing phenolic compounds biosynthesis and its relevance to abiotic stress tolerance in plants: a review.Antonie van Leeuwenhoek · 2025Review
- Paenibacillus peoriae: current knowledge and agricultural biotechnology potential of a close relative of P. polymyxa.Antonie van Leeuwenhoek · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Control of fungal phytopathogens is a significant challenge in modern agriculture. The widespread use of chemical fungicides to control these pathogens often leads to environmental and food contamination. An eco-friendly alternative that can help reduce reliance on these chemicals is plant growth-promoting bacteria (PGPB), particularly those of the genus Paenibacillus, which appear to be highly effective. The review aims to summarize the existing knowledge on the potential of Paenibacillus spp. as fungal biocontrol agents, identify knowledge gaps, and answer whether other species of the genus Paenibacillus, in addition to Paenibacillus polymyxa, can also be effective biocontrol agents. Paenibacillus spp. can combat plant phytopathogens through various mechanisms, including the production of lipopeptides (such as fusaricidin, paenimyxin, and pelgipeptin), the induction of systemic resistance (ISR), hydrolytic enzymes (chitinase, cellulase, and glucanase), and volatile organic compounds. These properties enable Paenibacillus strains to suppress the growth of fungi such as Fusarium oxysporum, F. solani, Rhizoctonia solani, Botrytis cinerea, or Colletotrichum gloeosporioides. Notably, several strains of Paenibacillus, including P. polymyxa, P. illinoisensis KJA-424, P. lentimorbus B-30488, and P. elgii JCK1400, have demonstrated efficacy in controlling fungal diseases in plants. Importantly, many formulations with Paenibacillus strains have already been patented, and some are commercially available, but most of them contain only P. polymyxa. Nevertheless, considering the data presented in this review, we believe that other strains from the Paenibacillus genus (besides P. polymyxa) will also be commercialized and used in plant protection in the future. Importantly, there is still limited information regarding their impact on the native microbiota, particularly from the metataxonomic and metagenomic perspectives. Expanding knowledge in this area could enhance the effectiveness of biocontrol agents containing Paenibacillus spp., ensuring safe and sustainable use of biological fungicides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.